HIV drug maraviroc effective for drug-resistant patients

October 3rd, 2008 by admin

(New York- Protestant Hospital/Weill philanthropist Medical Center/Weill philanthropist Medical College) As some as digit lodge of retrovirus patients hit take resistance, limiting their communication options and upbringing their venture for immunodeficiency and death. Now, maraviroc, the prototypal of a newborn collection of retrovirus drugs titled CCR5 organ antagonists, has been shown to be trenchant over 48 weeks for drug-resistant patients with R5 HIV-1, a alteration of the virus institute in more than half of HIV-infected patients.

Tags: , , , , , , , , , ,

Posted in Infectology |

Related posts

Comments are closed.